COVID-19 Impact on Global Metagenomics in Healthcare Market Size, Status and Forecast 2020-2026
Metagenomics is the study of genetic material recovered directly from environmental samples.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Metagenomics in Healthcare market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Metagenomics in Healthcare industry.
Based on our recent survey, we have several different scenarios about the Metagenomics in Healthcare YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Metagenomics in Healthcare will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Metagenomics in Healthcare market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Metagenomics in Healthcare market in terms of revenue.
Players, stakeholders, and other participants in the global Metagenomics in Healthcare market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Metagenomics in Healthcare market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Metagenomics in Healthcare market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Metagenomics in Healthcare market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Metagenomics in Healthcare market.
The following players are covered in this report:
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Metagenomics in Healthcare market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Metagenomics in Healthcare industry.
Based on our recent survey, we have several different scenarios about the Metagenomics in Healthcare YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Metagenomics in Healthcare will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Metagenomics in Healthcare market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Metagenomics in Healthcare market in terms of revenue.
Players, stakeholders, and other participants in the global Metagenomics in Healthcare market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Metagenomics in Healthcare market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Metagenomics in Healthcare market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Metagenomics in Healthcare market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Metagenomics in Healthcare market.
The following players are covered in this report:
- Illumina
- QIAGEN
- PerkinElmer
- Thermo Fisher Scientific
- Oxford Nanopore Technologies
- Sample Extraction Kits
- Metagenomics Kits
- Pharmaceutical Industries
- Biotechnology Companies
- Pathology Laboratories
- Academic and Research Laboratories
- Others
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Metagenomics in Healthcare Revenue
1.4 Market Analysis by Type
1.4.1 Global Metagenomics in Healthcare Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Sample Extraction Kits
1.4.3 Metagenomics Kits
1.5 Market by Application
1.5.1 Global Metagenomics in Healthcare Market Share by Application: 2020 VS 2026
1.5.2 Pharmaceutical Industries
1.5.3 Biotechnology Companies
1.5.4 Pathology Laboratories
1.5.5 Academic and Research Laboratories
1.5.6 Others
1.6 Coronavirus Disease 2019 (Covid-19): Metagenomics in Healthcare Industry Impact
1.6.1 How the Covid-19 is Affecting the Metagenomics in Healthcare Industry
1.6.1.1 Metagenomics in Healthcare Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Metagenomics in Healthcare Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Metagenomics in Healthcare Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 Metagenomics in Healthcare Market Perspective (2015-2026)
2.2 Metagenomics in Healthcare Growth Trends by Regions
2.2.1 Metagenomics in Healthcare Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Metagenomics in Healthcare Historic Market Share by Regions (2015-2020)
2.2.3 Metagenomics in Healthcare Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Metagenomics in Healthcare Market Growth Strategy
2.3.6 Primary Interviews with Key Metagenomics in Healthcare Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Metagenomics in Healthcare Players by Market Size
3.1.1 Global Top Metagenomics in Healthcare Players by Revenue (2015-2020)
3.1.2 Global Metagenomics in Healthcare Revenue Market Share by Players (2015-2020)
3.1.3 Global Metagenomics in Healthcare Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Metagenomics in Healthcare Market Concentration Ratio
3.2.1 Global Metagenomics in Healthcare Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Metagenomics in Healthcare Revenue in 2019
3.3 Metagenomics in Healthcare Key Players Head office and Area Served
3.4 Key Players Metagenomics in Healthcare Product Solution and Service
3.5 Date of Enter into Metagenomics in Healthcare Market
3.6 Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Metagenomics in Healthcare Historic Market Size by Type (2015-2020)
4.2 Global Metagenomics in Healthcare Forecasted Market Size by Type (2021-2026)
5 METAGENOMICS IN HEALTHCARE BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Metagenomics in Healthcare Market Size by Application (2015-2020)
5.2 Global Metagenomics in Healthcare Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Metagenomics in Healthcare Market Size (2015-2020)
6.2 Metagenomics in Healthcare Key Players in North America (2019-2020)
6.3 North America Metagenomics in Healthcare Market Size by Type (2015-2020)
6.4 North America Metagenomics in Healthcare Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe Metagenomics in Healthcare Market Size (2015-2020)
7.2 Metagenomics in Healthcare Key Players in Europe (2019-2020)
7.3 Europe Metagenomics in Healthcare Market Size by Type (2015-2020)
7.4 Europe Metagenomics in Healthcare Market Size by Application (2015-2020)
8 CHINA
8.1 China Metagenomics in Healthcare Market Size (2015-2020)
8.2 Metagenomics in Healthcare Key Players in China (2019-2020)
8.3 China Metagenomics in Healthcare Market Size by Type (2015-2020)
8.4 China Metagenomics in Healthcare Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan Metagenomics in Healthcare Market Size (2015-2020)
9.2 Metagenomics in Healthcare Key Players in Japan (2019-2020)
9.3 Japan Metagenomics in Healthcare Market Size by Type (2015-2020)
9.4 Japan Metagenomics in Healthcare Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia Metagenomics in Healthcare Market Size (2015-2020)
10.2 Metagenomics in Healthcare Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Metagenomics in Healthcare Market Size by Type (2015-2020)
10.4 Southeast Asia Metagenomics in Healthcare Market Size by Application (2015-2020)
11 INDIA
11.1 India Metagenomics in Healthcare Market Size (2015-2020)
11.2 Metagenomics in Healthcare Key Players in India (2019-2020)
11.3 India Metagenomics in Healthcare Market Size by Type (2015-2020)
11.4 India Metagenomics in Healthcare Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America Metagenomics in Healthcare Market Size (2015-2020)
12.2 Metagenomics in Healthcare Key Players in Central & South America (2019-2020)
12.3 Central & South America Metagenomics in Healthcare Market Size by Type (2015-2020)
12.4 Central & South America Metagenomics in Healthcare Market Size by Application (2015-2020)
13 KEY PLAYERS PROFILES
13.1 Illumina
13.1.1 Illumina Company Details
13.1.2 Illumina Business Overview and Its Total Revenue
13.1.3 Illumina Metagenomics in Healthcare Introduction
13.1.4 Illumina Revenue in Metagenomics in Healthcare Business (2015-2020))
13.1.5 Illumina Recent Development
13.2 QIAGEN
13.2.1 QIAGEN Company Details
13.2.2 QIAGEN Business Overview and Its Total Revenue
13.2.3 QIAGEN Metagenomics in Healthcare Introduction
13.2.4 QIAGEN Revenue in Metagenomics in Healthcare Business (2015-2020)
13.2.5 QIAGEN Recent Development
13.3 PerkinElmer
13.3.1 PerkinElmer Company Details
13.3.2 PerkinElmer Business Overview and Its Total Revenue
13.3.3 PerkinElmer Metagenomics in Healthcare Introduction
13.3.4 PerkinElmer Revenue in Metagenomics in Healthcare Business (2015-2020)
13.3.5 PerkinElmer Recent Development
13.4 Thermo Fisher Scientific
13.4.1 Thermo Fisher Scientific Company Details
13.4.2 Thermo Fisher Scientific Business Overview and Its Total Revenue
13.4.3 Thermo Fisher Scientific Metagenomics in Healthcare Introduction
13.4.4 Thermo Fisher Scientific Revenue in Metagenomics in Healthcare Business (2015-2020)
13.4.5 Thermo Fisher Scientific Recent Development
13.5 Oxford Nanopore Technologies
13.5.1 Oxford Nanopore Technologies Company Details
13.5.2 Oxford Nanopore Technologies Business Overview and Its Total Revenue
13.5.3 Oxford Nanopore Technologies Metagenomics in Healthcare Introduction
13.5.4 Oxford Nanopore Technologies Revenue in Metagenomics in Healthcare Business (2015-2020)
13.5.5 Oxford Nanopore Technologies Recent Development
14 ANALYST'S VIEWPOINTS/CONCLUSIONS
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Metagenomics in Healthcare Revenue
1.4 Market Analysis by Type
1.4.1 Global Metagenomics in Healthcare Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Sample Extraction Kits
1.4.3 Metagenomics Kits
1.5 Market by Application
1.5.1 Global Metagenomics in Healthcare Market Share by Application: 2020 VS 2026
1.5.2 Pharmaceutical Industries
1.5.3 Biotechnology Companies
1.5.4 Pathology Laboratories
1.5.5 Academic and Research Laboratories
1.5.6 Others
1.6 Coronavirus Disease 2019 (Covid-19): Metagenomics in Healthcare Industry Impact
1.6.1 How the Covid-19 is Affecting the Metagenomics in Healthcare Industry
1.6.1.1 Metagenomics in Healthcare Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Metagenomics in Healthcare Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Metagenomics in Healthcare Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 Metagenomics in Healthcare Market Perspective (2015-2026)
2.2 Metagenomics in Healthcare Growth Trends by Regions
2.2.1 Metagenomics in Healthcare Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Metagenomics in Healthcare Historic Market Share by Regions (2015-2020)
2.2.3 Metagenomics in Healthcare Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Metagenomics in Healthcare Market Growth Strategy
2.3.6 Primary Interviews with Key Metagenomics in Healthcare Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Metagenomics in Healthcare Players by Market Size
3.1.1 Global Top Metagenomics in Healthcare Players by Revenue (2015-2020)
3.1.2 Global Metagenomics in Healthcare Revenue Market Share by Players (2015-2020)
3.1.3 Global Metagenomics in Healthcare Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Metagenomics in Healthcare Market Concentration Ratio
3.2.1 Global Metagenomics in Healthcare Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Metagenomics in Healthcare Revenue in 2019
3.3 Metagenomics in Healthcare Key Players Head office and Area Served
3.4 Key Players Metagenomics in Healthcare Product Solution and Service
3.5 Date of Enter into Metagenomics in Healthcare Market
3.6 Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Metagenomics in Healthcare Historic Market Size by Type (2015-2020)
4.2 Global Metagenomics in Healthcare Forecasted Market Size by Type (2021-2026)
5 METAGENOMICS IN HEALTHCARE BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Metagenomics in Healthcare Market Size by Application (2015-2020)
5.2 Global Metagenomics in Healthcare Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Metagenomics in Healthcare Market Size (2015-2020)
6.2 Metagenomics in Healthcare Key Players in North America (2019-2020)
6.3 North America Metagenomics in Healthcare Market Size by Type (2015-2020)
6.4 North America Metagenomics in Healthcare Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe Metagenomics in Healthcare Market Size (2015-2020)
7.2 Metagenomics in Healthcare Key Players in Europe (2019-2020)
7.3 Europe Metagenomics in Healthcare Market Size by Type (2015-2020)
7.4 Europe Metagenomics in Healthcare Market Size by Application (2015-2020)
8 CHINA
8.1 China Metagenomics in Healthcare Market Size (2015-2020)
8.2 Metagenomics in Healthcare Key Players in China (2019-2020)
8.3 China Metagenomics in Healthcare Market Size by Type (2015-2020)
8.4 China Metagenomics in Healthcare Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan Metagenomics in Healthcare Market Size (2015-2020)
9.2 Metagenomics in Healthcare Key Players in Japan (2019-2020)
9.3 Japan Metagenomics in Healthcare Market Size by Type (2015-2020)
9.4 Japan Metagenomics in Healthcare Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia Metagenomics in Healthcare Market Size (2015-2020)
10.2 Metagenomics in Healthcare Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Metagenomics in Healthcare Market Size by Type (2015-2020)
10.4 Southeast Asia Metagenomics in Healthcare Market Size by Application (2015-2020)
11 INDIA
11.1 India Metagenomics in Healthcare Market Size (2015-2020)
11.2 Metagenomics in Healthcare Key Players in India (2019-2020)
11.3 India Metagenomics in Healthcare Market Size by Type (2015-2020)
11.4 India Metagenomics in Healthcare Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America Metagenomics in Healthcare Market Size (2015-2020)
12.2 Metagenomics in Healthcare Key Players in Central & South America (2019-2020)
12.3 Central & South America Metagenomics in Healthcare Market Size by Type (2015-2020)
12.4 Central & South America Metagenomics in Healthcare Market Size by Application (2015-2020)
13 KEY PLAYERS PROFILES
13.1 Illumina
13.1.1 Illumina Company Details
13.1.2 Illumina Business Overview and Its Total Revenue
13.1.3 Illumina Metagenomics in Healthcare Introduction
13.1.4 Illumina Revenue in Metagenomics in Healthcare Business (2015-2020))
13.1.5 Illumina Recent Development
13.2 QIAGEN
13.2.1 QIAGEN Company Details
13.2.2 QIAGEN Business Overview and Its Total Revenue
13.2.3 QIAGEN Metagenomics in Healthcare Introduction
13.2.4 QIAGEN Revenue in Metagenomics in Healthcare Business (2015-2020)
13.2.5 QIAGEN Recent Development
13.3 PerkinElmer
13.3.1 PerkinElmer Company Details
13.3.2 PerkinElmer Business Overview and Its Total Revenue
13.3.3 PerkinElmer Metagenomics in Healthcare Introduction
13.3.4 PerkinElmer Revenue in Metagenomics in Healthcare Business (2015-2020)
13.3.5 PerkinElmer Recent Development
13.4 Thermo Fisher Scientific
13.4.1 Thermo Fisher Scientific Company Details
13.4.2 Thermo Fisher Scientific Business Overview and Its Total Revenue
13.4.3 Thermo Fisher Scientific Metagenomics in Healthcare Introduction
13.4.4 Thermo Fisher Scientific Revenue in Metagenomics in Healthcare Business (2015-2020)
13.4.5 Thermo Fisher Scientific Recent Development
13.5 Oxford Nanopore Technologies
13.5.1 Oxford Nanopore Technologies Company Details
13.5.2 Oxford Nanopore Technologies Business Overview and Its Total Revenue
13.5.3 Oxford Nanopore Technologies Metagenomics in Healthcare Introduction
13.5.4 Oxford Nanopore Technologies Revenue in Metagenomics in Healthcare Business (2015-2020)
13.5.5 Oxford Nanopore Technologies Recent Development
14 ANALYST'S VIEWPOINTS/CONCLUSIONS
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
LIST OF TABLES
Table 1. Metagenomics in Healthcare Key Market Segments
Table 2. Key Players Covered: Ranking by Metagenomics in Healthcare Revenue
Table 3. Ranking of Global Top Metagenomics in Healthcare Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Metagenomics in Healthcare Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Sample Extraction Kits
Table 6. Key Players of Metagenomics Kits
Table 7. COVID-19 Impact Global Market: (Four Metagenomics in Healthcare Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Metagenomics in Healthcare Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Metagenomics in Healthcare Players to Combat Covid-19 Impact
Table 12. Global Metagenomics in Healthcare Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Metagenomics in Healthcare Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Metagenomics in Healthcare Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Metagenomics in Healthcare Market Share by Regions (2015-2020)
Table 16. Global Metagenomics in Healthcare Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Metagenomics in Healthcare Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Metagenomics in Healthcare Market Growth Strategy
Table 22. Main Points Interviewed from Key Metagenomics in Healthcare Players
Table 23. Global Metagenomics in Healthcare Revenue by Players (2015-2020) (Million US$)
Table 24. Global Metagenomics in Healthcare Market Share by Players (2015-2020)
Table 25. Global Top Metagenomics in Healthcare Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Metagenomics in Healthcare as of 2019)
Table 26. Global Metagenomics in Healthcare by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Metagenomics in Healthcare Product Solution and Service
Table 29. Date of Enter into Metagenomics in Healthcare Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Metagenomics in Healthcare Market Size by Type (2015-2020) (Million US$)
Table 32. Global Metagenomics in Healthcare Market Size Share by Type (2015-2020)
Table 33. Global Metagenomics in Healthcare Revenue Market Share by Type (2021-2026)
Table 34. Global Metagenomics in Healthcare Market Size Share by Application (2015-2020)
Table 35. Global Metagenomics in Healthcare Market Size by Application (2015-2020) (Million US$)
Table 36. Global Metagenomics in Healthcare Market Size Share by Application (2021-2026)
Table 37. North America Key Players Metagenomics in Healthcare Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Metagenomics in Healthcare Market Share (2019-2020)
Table 39. North America Metagenomics in Healthcare Market Size by Type (2015-2020) (Million US$)
Table 40. North America Metagenomics in Healthcare Market Share by Type (2015-2020)
Table 41. North America Metagenomics in Healthcare Market Size by Application (2015-2020) (Million US$)
Table 42. North America Metagenomics in Healthcare Market Share by Application (2015-2020)
Table 43. Europe Key Players Metagenomics in Healthcare Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Metagenomics in Healthcare Market Share (2019-2020)
Table 45. Europe Metagenomics in Healthcare Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Metagenomics in Healthcare Market Share by Type (2015-2020)
Table 47. Europe Metagenomics in Healthcare Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Metagenomics in Healthcare Market Share by Application (2015-2020)
Table 49. China Key Players Metagenomics in Healthcare Revenue (2019-2020) (Million US$)
Table 50. China Key Players Metagenomics in Healthcare Market Share (2019-2020)
Table 51. China Metagenomics in Healthcare Market Size by Type (2015-2020) (Million US$)
Table 52. China Metagenomics in Healthcare Market Share by Type (2015-2020)
Table 53. China Metagenomics in Healthcare Market Size by Application (2015-2020) (Million US$)
Table 54. China Metagenomics in Healthcare Market Share by Application (2015-2020)
Table 55. Japan Key Players Metagenomics in Healthcare Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Metagenomics in Healthcare Market Share (2019-2020)
Table 57. Japan Metagenomics in Healthcare Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Metagenomics in Healthcare Market Share by Type (2015-2020)
Table 59. Japan Metagenomics in Healthcare Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Metagenomics in Healthcare Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Metagenomics in Healthcare Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Metagenomics in Healthcare Market Share (2019-2020)
Table 63. Southeast Asia Metagenomics in Healthcare Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Metagenomics in Healthcare Market Share by Type (2015-2020)
Table 65. Southeast Asia Metagenomics in Healthcare Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Metagenomics in Healthcare Market Share by Application (2015-2020)
Table 67. India Key Players Metagenomics in Healthcare Revenue (2019-2020) (Million US$)
Table 68. India Key Players Metagenomics in Healthcare Market Share (2019-2020)
Table 69. India Metagenomics in Healthcare Market Size by Type (2015-2020) (Million US$)
Table 70. India Metagenomics in Healthcare Market Share by Type (2015-2020)
Table 71. India Metagenomics in Healthcare Market Size by Application (2015-2020) (Million US$)
Table 72. India Metagenomics in Healthcare Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Metagenomics in Healthcare Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Metagenomics in Healthcare Market Share (2019-2020)
Table 75. Central & South America Metagenomics in Healthcare Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Metagenomics in Healthcare Market Share by Type (2015-2020)
Table 77. Central & South America Metagenomics in Healthcare Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Metagenomics in Healthcare Market Share by Application (2015-2020)
Table 79. Illumina Company Details
Table 80. Illumina Business Overview
Table 81. Illumina Product
Table 82. Illumina Revenue in Metagenomics in Healthcare Business (2015-2020) (Million US$)
Table 83. Illumina Recent Development
Table 84. QIAGEN Company Details
Table 85. QIAGEN Business Overview
Table 86. QIAGEN Product
Table 87. QIAGEN Revenue in Metagenomics in Healthcare Business (2015-2020) (Million US$)
Table 88. QIAGEN Recent Development
Table 89. PerkinElmer Company Details
Table 90. PerkinElmer Business Overview
Table 91. PerkinElmer Product
Table 92. PerkinElmer Revenue in Metagenomics in Healthcare Business (2015-2020) (Million US$)
Table 93. PerkinElmer Recent Development
Table 94. Thermo Fisher Scientific Company Details
Table 95. Thermo Fisher Scientific Business Overview
Table 96. Thermo Fisher Scientific Product
Table 97. Thermo Fisher Scientific Revenue in Metagenomics in Healthcare Business (2015-2020) (Million US$)
Table 98. Thermo Fisher Scientific Recent Development
Table 99. Oxford Nanopore Technologies Company Details
Table 100. Oxford Nanopore Technologies Business Overview
Table 101. Oxford Nanopore Technologies Product
Table 102. Oxford Nanopore Technologies Revenue in Metagenomics in Healthcare Business (2015-2020) (Million US$)
Table 103. Oxford Nanopore Technologies Recent Development
Table 104. Research Programs/Design for This Report
Table 105. Key Data Information from Secondary Sources
Table 106. Key Data Information from Primary Sources
Table 1. Metagenomics in Healthcare Key Market Segments
Table 2. Key Players Covered: Ranking by Metagenomics in Healthcare Revenue
Table 3. Ranking of Global Top Metagenomics in Healthcare Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Metagenomics in Healthcare Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Sample Extraction Kits
Table 6. Key Players of Metagenomics Kits
Table 7. COVID-19 Impact Global Market: (Four Metagenomics in Healthcare Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Metagenomics in Healthcare Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Metagenomics in Healthcare Players to Combat Covid-19 Impact
Table 12. Global Metagenomics in Healthcare Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Metagenomics in Healthcare Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Metagenomics in Healthcare Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Metagenomics in Healthcare Market Share by Regions (2015-2020)
Table 16. Global Metagenomics in Healthcare Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Metagenomics in Healthcare Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Metagenomics in Healthcare Market Growth Strategy
Table 22. Main Points Interviewed from Key Metagenomics in Healthcare Players
Table 23. Global Metagenomics in Healthcare Revenue by Players (2015-2020) (Million US$)
Table 24. Global Metagenomics in Healthcare Market Share by Players (2015-2020)
Table 25. Global Top Metagenomics in Healthcare Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Metagenomics in Healthcare as of 2019)
Table 26. Global Metagenomics in Healthcare by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Metagenomics in Healthcare Product Solution and Service
Table 29. Date of Enter into Metagenomics in Healthcare Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Metagenomics in Healthcare Market Size by Type (2015-2020) (Million US$)
Table 32. Global Metagenomics in Healthcare Market Size Share by Type (2015-2020)
Table 33. Global Metagenomics in Healthcare Revenue Market Share by Type (2021-2026)
Table 34. Global Metagenomics in Healthcare Market Size Share by Application (2015-2020)
Table 35. Global Metagenomics in Healthcare Market Size by Application (2015-2020) (Million US$)
Table 36. Global Metagenomics in Healthcare Market Size Share by Application (2021-2026)
Table 37. North America Key Players Metagenomics in Healthcare Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Metagenomics in Healthcare Market Share (2019-2020)
Table 39. North America Metagenomics in Healthcare Market Size by Type (2015-2020) (Million US$)
Table 40. North America Metagenomics in Healthcare Market Share by Type (2015-2020)
Table 41. North America Metagenomics in Healthcare Market Size by Application (2015-2020) (Million US$)
Table 42. North America Metagenomics in Healthcare Market Share by Application (2015-2020)
Table 43. Europe Key Players Metagenomics in Healthcare Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Metagenomics in Healthcare Market Share (2019-2020)
Table 45. Europe Metagenomics in Healthcare Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Metagenomics in Healthcare Market Share by Type (2015-2020)
Table 47. Europe Metagenomics in Healthcare Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Metagenomics in Healthcare Market Share by Application (2015-2020)
Table 49. China Key Players Metagenomics in Healthcare Revenue (2019-2020) (Million US$)
Table 50. China Key Players Metagenomics in Healthcare Market Share (2019-2020)
Table 51. China Metagenomics in Healthcare Market Size by Type (2015-2020) (Million US$)
Table 52. China Metagenomics in Healthcare Market Share by Type (2015-2020)
Table 53. China Metagenomics in Healthcare Market Size by Application (2015-2020) (Million US$)
Table 54. China Metagenomics in Healthcare Market Share by Application (2015-2020)
Table 55. Japan Key Players Metagenomics in Healthcare Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Metagenomics in Healthcare Market Share (2019-2020)
Table 57. Japan Metagenomics in Healthcare Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Metagenomics in Healthcare Market Share by Type (2015-2020)
Table 59. Japan Metagenomics in Healthcare Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Metagenomics in Healthcare Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Metagenomics in Healthcare Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Metagenomics in Healthcare Market Share (2019-2020)
Table 63. Southeast Asia Metagenomics in Healthcare Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Metagenomics in Healthcare Market Share by Type (2015-2020)
Table 65. Southeast Asia Metagenomics in Healthcare Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Metagenomics in Healthcare Market Share by Application (2015-2020)
Table 67. India Key Players Metagenomics in Healthcare Revenue (2019-2020) (Million US$)
Table 68. India Key Players Metagenomics in Healthcare Market Share (2019-2020)
Table 69. India Metagenomics in Healthcare Market Size by Type (2015-2020) (Million US$)
Table 70. India Metagenomics in Healthcare Market Share by Type (2015-2020)
Table 71. India Metagenomics in Healthcare Market Size by Application (2015-2020) (Million US$)
Table 72. India Metagenomics in Healthcare Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Metagenomics in Healthcare Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Metagenomics in Healthcare Market Share (2019-2020)
Table 75. Central & South America Metagenomics in Healthcare Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Metagenomics in Healthcare Market Share by Type (2015-2020)
Table 77. Central & South America Metagenomics in Healthcare Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Metagenomics in Healthcare Market Share by Application (2015-2020)
Table 79. Illumina Company Details
Table 80. Illumina Business Overview
Table 81. Illumina Product
Table 82. Illumina Revenue in Metagenomics in Healthcare Business (2015-2020) (Million US$)
Table 83. Illumina Recent Development
Table 84. QIAGEN Company Details
Table 85. QIAGEN Business Overview
Table 86. QIAGEN Product
Table 87. QIAGEN Revenue in Metagenomics in Healthcare Business (2015-2020) (Million US$)
Table 88. QIAGEN Recent Development
Table 89. PerkinElmer Company Details
Table 90. PerkinElmer Business Overview
Table 91. PerkinElmer Product
Table 92. PerkinElmer Revenue in Metagenomics in Healthcare Business (2015-2020) (Million US$)
Table 93. PerkinElmer Recent Development
Table 94. Thermo Fisher Scientific Company Details
Table 95. Thermo Fisher Scientific Business Overview
Table 96. Thermo Fisher Scientific Product
Table 97. Thermo Fisher Scientific Revenue in Metagenomics in Healthcare Business (2015-2020) (Million US$)
Table 98. Thermo Fisher Scientific Recent Development
Table 99. Oxford Nanopore Technologies Company Details
Table 100. Oxford Nanopore Technologies Business Overview
Table 101. Oxford Nanopore Technologies Product
Table 102. Oxford Nanopore Technologies Revenue in Metagenomics in Healthcare Business (2015-2020) (Million US$)
Table 103. Oxford Nanopore Technologies Recent Development
Table 104. Research Programs/Design for This Report
Table 105. Key Data Information from Secondary Sources
Table 106. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Metagenomics in Healthcare Market Share by Type: 2020 VS 2026
Figure 2. Sample Extraction Kits Features
Figure 3. Metagenomics Kits Features
Figure 4. Global Metagenomics in Healthcare Market Share by Application: 2020 VS 2026
Figure 5. Pharmaceutical Industries Case Studies
Figure 6. Biotechnology Companies Case Studies
Figure 7. Pathology Laboratories Case Studies
Figure 8. Academic and Research Laboratories Case Studies
Figure 9. Others Case Studies
Figure 10. Metagenomics in Healthcare Report Years Considered
Figure 11. Global Metagenomics in Healthcare Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Metagenomics in Healthcare Market Share by Regions: 2020 VS 2026
Figure 13. Global Metagenomics in Healthcare Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Metagenomics in Healthcare Market Share by Players in 2019
Figure 16. Global Top Metagenomics in Healthcare Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Metagenomics in Healthcare as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Metagenomics in Healthcare Revenue in 2019
Figure 18. North America Metagenomics in Healthcare Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Metagenomics in Healthcare Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Metagenomics in Healthcare Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Metagenomics in Healthcare Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Metagenomics in Healthcare Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Metagenomics in Healthcare Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Metagenomics in Healthcare Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Illumina Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Illumina Revenue Growth Rate in Metagenomics in Healthcare Business (2015-2020)
Figure 27. QIAGEN Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. QIAGEN Revenue Growth Rate in Metagenomics in Healthcare Business (2015-2020)
Figure 29. PerkinElmer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. PerkinElmer Revenue Growth Rate in Metagenomics in Healthcare Business (2015-2020)
Figure 31. Thermo Fisher Scientific Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Thermo Fisher Scientific Revenue Growth Rate in Metagenomics in Healthcare Business (2015-2020)
Figure 33. Oxford Nanopore Technologies Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Oxford Nanopore Technologies Revenue Growth Rate in Metagenomics in Healthcare Business (2015-2020)
Figure 35. Bottom-up and Top-down Approaches for This Report
Figure 36. Data Triangulation
Figure 37. Key Executives Interviewed
Figure 1. Global Metagenomics in Healthcare Market Share by Type: 2020 VS 2026
Figure 2. Sample Extraction Kits Features
Figure 3. Metagenomics Kits Features
Figure 4. Global Metagenomics in Healthcare Market Share by Application: 2020 VS 2026
Figure 5. Pharmaceutical Industries Case Studies
Figure 6. Biotechnology Companies Case Studies
Figure 7. Pathology Laboratories Case Studies
Figure 8. Academic and Research Laboratories Case Studies
Figure 9. Others Case Studies
Figure 10. Metagenomics in Healthcare Report Years Considered
Figure 11. Global Metagenomics in Healthcare Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Metagenomics in Healthcare Market Share by Regions: 2020 VS 2026
Figure 13. Global Metagenomics in Healthcare Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Metagenomics in Healthcare Market Share by Players in 2019
Figure 16. Global Top Metagenomics in Healthcare Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Metagenomics in Healthcare as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Metagenomics in Healthcare Revenue in 2019
Figure 18. North America Metagenomics in Healthcare Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Metagenomics in Healthcare Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Metagenomics in Healthcare Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Metagenomics in Healthcare Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Metagenomics in Healthcare Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Metagenomics in Healthcare Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Metagenomics in Healthcare Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Illumina Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Illumina Revenue Growth Rate in Metagenomics in Healthcare Business (2015-2020)
Figure 27. QIAGEN Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. QIAGEN Revenue Growth Rate in Metagenomics in Healthcare Business (2015-2020)
Figure 29. PerkinElmer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. PerkinElmer Revenue Growth Rate in Metagenomics in Healthcare Business (2015-2020)
Figure 31. Thermo Fisher Scientific Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Thermo Fisher Scientific Revenue Growth Rate in Metagenomics in Healthcare Business (2015-2020)
Figure 33. Oxford Nanopore Technologies Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Oxford Nanopore Technologies Revenue Growth Rate in Metagenomics in Healthcare Business (2015-2020)
Figure 35. Bottom-up and Top-down Approaches for This Report
Figure 36. Data Triangulation
Figure 37. Key Executives Interviewed
